Bayer is exiting the seed treatment equipment business in the United States to help the company's finances, according to an ...

Bayer has overturned a ruling that it brought discredit on the pharma industry. | Bayer has overturned a ruling that it ...

In a recent study conducted by Navaneethan and colleagues and published in the International Society of Nephrology, the ...

Bayer on April 1 showcased significant advancements in its pharmaceutical growth strategy and pipeline at its annual Pharma Media Day. As part of the ongoing transformation of its pharmaceutical ...

Bayer is lobbying U.S. states to adjust their regulations in the battle to control costly litigation targeting its herbicide ...

German pharmaceuticals and agrichemicals firm Bayer said Friday it could be forced to pull its Roundup weedkiller from the ...

and the Bayer Cross was used as the trademark for all of the I.G.'s pharmaceutical products. In the early 1930s, the Wupperal-Elberfeld facility continued its successful research into drugs to ...

German pharmaceuticals and agrichemicals firm Bayer said Friday it could be forced to pull its Roundup weedkiller from the market if it is not able to contain simmering legal troubles.

However, Bayer's top-selling pharma product Xarelto (rivaroxaban), an anticoagulant, continued to succumb to generic competition with a near-11% fall to €904 million. The solid quarter is ...

UK MHRA grants marketing approval for BridgeBio Pharma’s Beyonttra to treat ATTR-CM: Palo Alto, California Wednesday, April 30, 2025, 16:00 Hrs [IST] BridgeBio Pharma, Inc., a n ...